Original Article

CME Article: Skin Cancer in Non-White Solid Organ Transplant Recipients: Mayo Clinic Experience

Authors: Daniel Zieman, MD, Michael Heckman, MS, Danielle Brushaber, BS, Catherine Degesys, MD, Leila Tolaymat, MD


Objective: Solid organ transplant recipients (SOTRs) have an increased risk of skin cancer development, but limited data exist on the development pattern of cutaneous malignancies in non-White SOTRs. The aim of this study was to describe the characteristics and outcomes of non-White patients who developed skin cancer following solid organ transplantation.

Methods: We conducted a retrospective chart review of non-White SOTRs at the Mayo Clinic who underwent transplantation between November 1987 and April 2020 and subsequently developed skin cancer.

Results: We identified 32 non-White SOTRs who developed skin cancer in the posttransplant period. Among these, 46.9% were Hispanic/Latinx, 25% were American Indian/Alaskan Native, 21.9% were Asian, and 6.3% were Black/African American. Four patients had a history of nonmelanoma skin cancer pretransplant. In regard to skin cancer type, 21 (65.6%) patients developed squamous cell carcinoma, 15 (46.9%) developed basal cell carcinoma, 5 (15.6%) developed melanoma, and 2 (6.3%) developed sebaceous carcinoma. The median time from transplant to first posttransplant skin cancer was 7.8 years.

Conclusions: Our study provides further characterization of the development of skin cancer in non-White SOTRs following transplant and identifies a variety of relevant pre- and posttransplant factors. Despite a long follow-up period, the number of patients identified remained low, which is consistent with the literature, indicating a low incidence of skin cancer development in non-White SOTRs. Continued investigation may allow for a more precise identification of risk factors and their degree of significance.
Posted in: Dermatology10

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681–1691.
2. Garrett GL, Blanc PD, Boscardin J, et al. Incidence of and risk factors for skin cancer in organ transplant recipients in the United States. JAMA Dermatol 2017;153:296–303.
3. Gogia R, Binstock M, Hirose R, et al. Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation. J Am Acad Dermatol 2013;68:585–591.
4. Bhat M, Mara K, Dierkhising R, et al. Gender, race and disease etiology predict de novo malignancy risk after liver transplantation: insights for future individualized cancer screening guidance. Transplantation 2019;103:91–100.
5. Buoy AG, Yoo S, Alam M, et al. Distribution of skin type and skin cancer in organ transplant recipients. Arch Dermatol 2010;146:344–346.
6. Tufaro AP, Azoury SC, Crompton JG, et al. Rising incidence and aggressive nature of cutaneous malignancies after transplantation: an update on epidemiology, risk factors, management and surveillance. Surg Oncol 2015;24: 345–352.
7. United Network for Organ Sharing. National data. https://optn.transplant.hrsa.gov/data/view-data-reports/national-data. Accessed November 21, 2022.
8. Crow LD, Jambusaria-Pahlajani A, Chung CL, et al. Initial skin cancer screening for solid organ transplant recipients in the United States: Delphi method development of expert consensus guidelines. Transpl Int 2019;32:1268–1276.
9. Tolaymat LM, Reimer DK, Feig J, et al. Skin cancer in non-white liver transplant recipients: Mayo Clinic experience. Int J Dermatol 2021;60:986–990.
10. Pritchett EN, Doyle A, Shaver CM, et al. Nonmelanoma skin cancer in nonwhite organ transplant recipients. JAMA Dermatol 2016;152:1348–1353.
11. Chung CL, Nadhan KS, Shaver CM, et al. Comparison of posttransplant dermatologic diseases by race. JAMA Dermatol 2017;153:552–558.
12. Ruiz DE, Luzuriaga AM, Hsieh C. Yearly burden of skin cancer in non-caucasian and caucasian solid-organ transplant recipients. J Clin Aesthet Dermatol 2015;8:16–19.
13. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002;47:1–20.
14. Comeau S, Jensen L, Cockfield SM, et al. Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience. Transplantation 2008;86:535–541.
15. Stasko T, Brown MD, Carucci JA, et al; International Transplant-Skin Cancer Collaborative; European Skin Care in Organ Transplant Patients Network. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004;30(4 Pt 2):642–650.
16. Harwood CA, Leedham-Green M, Leigh IM, et al. Low-dose retinoids in the prevention of cutaneous squamous cell carcinomas in organ transplant recipients: a 16-year retrospective study. Arch Dermatol 2005;141: 456–464.
17. Neuhaus IM, Tope WD. Practical retinoid chemoprophylaxis in solid organ transplant recipients. Dermatol Ther 2005;18:28–33.
18. Otley CC, Maragh SL. Reduction of immunosuppression for transplantassociated skin cancer: rationale and evidence of efficacy. Dermatol Surg 2005;31:163–168.
19. Carucci JA, Martinez JC, Zeitouni NC, et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004;30(4 Pt 2): 651–655.
20. Martinez JC, Otley CC, Stasko T, et al; Transplant-Skin Cancer Collaborative. Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003;139:301–306.
21. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995;75(2 suppl):667–673.
22. Bang KM, Halder RM, White JE, et al. Skin cancer in black Americans: a review of 126 cases. J Natl Med Assoc 1987;79:51–58.
23. Lundsford NB, Berktold J, Holman DM, et al. Skin cancer knowledge, awareness, beliefs and preventive behaviors among Black and Hispanic men and women. Prev Med Rep 2018;12:203–209.